Decreased trabecular bone score but not bone mineral density in patients with acromegaly and concurrent hypogonadism: cross-sectional study with healthy controls

2017 ◽  
Author(s):  
Martin Kužma ◽  
Dušan Pavai ◽  
Ivana Sagova ◽  
Zdenko Killinger ◽  
Peter Jackuliak ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Trabecular Bone ◽  
Bone Mineral ◽  
Trabecular Bone Score ◽  
Cross Sectional Study ◽  
Healthy Controls ◽  
Sectional Study ◽  
Mineral Density ◽  
Cross Sectional

Trabecular bone score and bone mineral density in acromegalic osteopathy assessment: a cross-sectional study

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Madalina Cristina Sorohan ◽  
Roxana Dusceac ◽  
Bogdan Marian Sorohan ◽  
Andra Caragheorgheopol ◽  
Catalina Poiana
Keyword(s):  
Bone Mineral Density ◽  
Trabecular Bone ◽  
Bone Mineral ◽  
Trabecular Bone Score ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Mineral Density ◽  
Cross Sectional

scholarly journals Bone mineral density and trabecular bone score assessment in systemic sclerosis: a cross-sectional study

2021 ◽  
pp. 105214
Author(s):  
Alain Lescoat ◽  
Marie Leroy ◽  
Guillaume Coiffier ◽  
Claire Cazalets ◽  
Nicolas Belhomme ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Systemic Sclerosis ◽  
Trabecular Bone ◽  
Bone Mineral ◽  
Trabecular Bone Score ◽  
Cross Sectional Study ◽  
Sectional Study ◽  
Mineral Density ◽  
Cross Sectional

scholarly journals Fibroblast Growth Factor 23 and Klotho Are Associated With Trabecular Bone Score but Not Bone Mineral Density in the Early Stages of Chronic Kidney Disease: Results of the Cross-Sectional Study

2021 ◽  
pp. S43-S51
Author(s):  
Z. Kužmová ◽  
M. Kužma ◽  
A. Gažová ◽  
M. Kovářová ◽  
P. Jackuliak ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Trabecular Bone ◽  
Bone Mineral ◽  
Trabecular Bone Score ◽  
Fibroblast Growth Factor 23 ◽  
Cross Sectional Study ◽  
Mineral Density ◽  
Cross Sectional ◽  
Group A ◽  
Group B

This study evaluates bone mineral density (BMD) and trabecular bone score (TBS) in relationship with new markers of chronic kidney disease (CKD), fibroblast growth factor 23 (FGF23), and klotho. The patients in this cross-sectional study were divided as follows: group A -patients in stages G1-3; group B -patients in stages G4 – 5 according to KDIGO. Plasma levels of soluble klotho and FGF23 were determined by ELISA. Bone mineral density (BMD) and trabecular bone score (TBS) were measured. 74 patients with CKD (mean age 68.8 years) were included in the study. Higher levels of FGF23 were observed in group B (N=15) compared to group A (N=59; p=0.001) were observed. FGF23 was higher in group A compared to group B. Significant difference in TBS within the first 3 stages of CKD was observed (mean TBS in G1=1.375 vs. G2=1.340 vs. G3a=1.24; p<0.05) and negative correlation of FGF23 and TBS (R=-0.33; p=0.05) and positive correlation between klotho and TBS (R=0.419; p=0.04) was observed. This study confirmed that FGF23 and klotho are associated with TBS, but TBS reflects a decrease in kidney function only in the first 3 stages of CKD. Thus, FGF23 and klotho together with TBS are promising markers of early trabecular bone impairment in CKD.

Author response for "Association of Beta Blocker Use with Bone Mineral Density in the Framingham Osteoporosis Study: a Cross‐sectional Study"

2020 ◽  
Author(s):  
Christine W. Lary ◽  
Alexandra C. Hinton ◽  
Kathleen T. Nevola ◽  
Theresa I. Shireman ◽  
Katherine Motyl ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Beta Blocker ◽  
Cross Sectional Study ◽  
Author Response ◽  
Sectional Study ◽  
Mineral Density ◽  
Cross Sectional

scholarly journals Somatic maturation and the relationship between bone mineral variables and types of sports among adolescents: cross-sectional study

2017 ◽  
Vol 135 (3) ◽  
pp. 253-259 ◽  
Author(s):  
Ricardo Ribeiro Agostinete ◽  
Igor Hideki Ito ◽  
Han Kemper ◽  
Carlos Marcelo Pastre ◽  
Mário Antônio Rodrigues-Júnior ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Peak Height ◽  
Cross Sectional Study ◽  
Height Velocity ◽  
Whole Body ◽  
Sectional Study ◽  
Peak Height Velocity ◽  
Mineral Density ◽  
Cross Sectional

ABSTRACT CONTEXT AND OBJECTIVE: Peak height velocity (PHV) is an important maturational event during adolescence that affects skeleton size. The objective here was to compare bone variables in adolescents who practiced different types of sports, and to identify whether differences in bone variables attributed to sports practice were dependent on somatic maturation status. DESIGN AND SETTING: Cross-sectional study, São Paulo State University (UNESP). METHODS: The study was composed of 93 adolescents (12 to 16.5 years old), divided into three groups: no-sport group (n = 42), soccer/basketball group (n = 26) and swimming group (n = 25). Bone mineral density and content were measured using dual-energy x-ray absorptiometry and somatic maturation was estimated through using peak height velocity. Data on training load were provided by the coaches. RESULTS: Adolescents whose PHV occurred at an older age presented higher bone mineral density in their upper limbs (P = 0.018). After adjustments for confounders, such as somatic maturation, the swimmers presented lower values for bone mineral density in their lower limbs, spine and whole body. Only the bone mineral density in the upper limbs was similar between the groups. There was a negative relationship between whole-body bone mineral content and the weekly training hours (β: -1563.967; 95% confidence interval, CI: -2916.484 to -211.450). CONCLUSION: The differences in bone variables attributed to sport practice occurred independently of maturation, while high training load in situations of hypogravity seemed to be related to lower bone mass in swimmers.

Sign in / Sign up

Export Citation Format

Share Document